SUNSHINE BIOPHARMA INC. — Earnings
Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR
Next earnings (estimated): Wed, April 1, 2026 — 27 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)
Recent earnings · last 8 quarters
| Quarter end | Revenue | YoY | Net Income | YoY | Op. Margin |
|---|---|---|---|---|---|
| 2025-12-31 | $9M | ↓-10.6% | — | — | — |
| 2025-09-30 | $9M | ↑+11.6% | $-884K | ↑+26.2% | -11.5% |
| 2025-06-30 | $9M | ↑+1.2% | $-2M | ↓-258.3% | -21.8% |
| 2025-03-31 | $9M | ↑+18.0% | $-1M | ↑+8.1% | -14.6% |
| 2024-12-31 | $10M | ↑+24.9% | — | — | — |
| 2024-09-30 | $8M | ↑+41.6% | $-1M | ↓-83.9% | -13.1% |
| 2024-06-30 | $9M | ↑+67.3% | $-494K | ↑+45.2% | -13.6% |
| 2024-03-31 | $8M | ↑+54.1% | $-1M | ↑+24.6% | -17.9% |
Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.
Last earnings · FY2025 (Q4)
Revenue
$9M
↓-10.6% -$1M YoY
Net Income
$3M
↓-6.0% -$172K YoY
Earnings surprise · last 8 quarters
YoY % change · proxy for analyst surprise until estimates landEPS history · last 10 fiscal years
diluted, GAAP, annualNote: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.
Margin trends · 65 quarters
margin trajectory tells the operating-leverage storyGross Margin↑+3.1pts
35.3%
Operating Margin↑+1.6pts
-11.5%
Net Margin↑+4.8pts
-9.4%
Go deeper
SBFM Sankey — flow of dollars
See how revenue waterfalls through every line item to net income for the latest reported quarter, with prior-period comparison.
Open SankeySBFM Key Metrics — EPS, ROE, ROIC
10 CFA-grade fundamental ratios — EPS, BVPS, ROE, ROA, ROIC, Debt/Equity, Current Ratio. Compare across years.
Open Key Metrics